Search

Mirati Therapeutics Inc

Suletud

SektorTervishoid

0

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

Max

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

-0.05% downside

Uudiste sentiment

By Acuity

34%

66%

86 / 340 Pingereas Healthcare

Mirati Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. aug 2026, 00:06 UTC

News

Berkshire Hathaway increased its stake in New York Times Co. to 15.7 million shares, contributing to a modest rise in after-market hours.

15. aug 2026, 00:02 UTC

News

AeroVironment appointed Michael D. Ruppert to its Board of Directors as Charles Burbage plans to retire in 2026. Shares are lower in after-market trading.

15. aug 2026, 00:02 UTC

News

Shares of Photronics Inc lower in after-hours trading amid a class action lawsuit alleging securities fraud related to misleading statements about its product pipeline.

15. aug 2026, 00:02 UTC

Social Media
News

Berkshire Hathaway's new position in DR Horton increased investor interest, contributing to a rise in the stock during after-hours trading.

15. aug 2026, 00:02 UTC

News

Planet Fitness Inc. shares are higher in after-market trading, reflecting positive sentiment following recent performance despite remaining below the 20-day moving average.

15. aug 2026, 00:02 UTC

News

Berkshire Hathaway has dissolved its stake in Constellation Brands, contributing to a decline in shares during after-market hours. The stock remains above its 20-day moving average.

15. aug 2026, 00:02 UTC

News

Target Corp shares are lower in after-market hours despite Telsey Advisory Group raising its price target to $170 and maintaining an Outperform rating.

15. aug 2026, 00:02 UTC

News

Realty Income Corp closed a $1.0 billion private offering of convertible senior notes and is trading higher in after-market hours.

15. aug 2026, 00:02 UTC

News

Texas Pacific Land shares rise in after-market trading, continuing a trend of gains. The company's market cap stands at $24.75 billion.

15. aug 2026, 00:01 UTC

News

Soros Fund Management LLC reduced its stake in Blue Owl Capital Inc by 51.8% to 973,500 shares, contributing to negative sentiment. Shares are roughly flat in after-market trading.

15. aug 2026, 00:01 UTC

News

Elliott Investment Management increased its stake in Hewlett Packard Enterprise to 32.3 million shares. Shares were roughly flat in after-market trading.

15. aug 2026, 00:01 UTC

News
Social Media

Genco Shipping & Trading shares decline in after-market trading following Diana Shipping's withdrawal of its acquisition offer due to unrealistic demands from Genco's Board.

15. aug 2026, 00:01 UTC

News

Wix.Com Ltd faces a class action lawsuit over alleged securities law violations related to its AI products, with shares trading lower in after-market hours.

15. aug 2026, 00:01 UTC

News

Jana Partners disclosed a new stake in Rapid7, contributing to positive sentiment. In after-market trading, shares recovered and traded higher since Friday's close.

15. aug 2026, 00:01 UTC

News

Embecta Corp shares are lower in after-market trading amid two class action lawsuits alleging securities fraud and a significant revenue decline.

14. aug 2026, 23:52 UTC

News

Boeing Co secures over $711 million in U.S. defense contract modifications, boosting investor sentiment. Shares are higher in after-market trading.

14. aug 2026, 23:51 UTC

News

PayPal is in advanced talks for a potential sale to Stripe and Advent, following a proposal of $60.50 per share. Shares are higher in after-market trading.

14. aug 2026, 23:51 UTC

News

Tyson Foods will close its beef facility in Joslin, Illinois, resulting in about 2,500 job losses, as shares trade lower in after-market hours.

14. aug 2026, 23:46 UTC

News

Replimune Group Inc shares are lower in after-market hours amid negative sentiment from a securities fraud lawsuit related to its RP1 application.

14. aug 2026, 23:46 UTC

News

Delek US Holdings shares rose in after-market hours following Delek Logistics Partners' $230 million public offering of common units at $50.00 each.

14. aug 2026, 23:46 UTC

News

Patterson-UTI Energy reported 98 drilling rigs operating in July. Shares rose in after-market trading, reflecting strong activity and nearing the upper end of their one-month range.

14. aug 2026, 23:46 UTC

News

Kraft Heinz Co shares are lower in after-market trading following a $100 million marketing announcement and concerns over July's U.S. retail sales drop.

14. aug 2026, 23:41 UTC

News

Elliott Investment Management increased its stake in Hewlett Packard Enterprise by 17.7%, contributing to higher after-market trading for the shares.

14. aug 2026, 23:36 UTC

News

Dynatrace shares are higher in after-hours trading following Starboard Value's SEC filing disclosing an 8.9 million share stake.

14. aug 2026, 23:31 UTC

News

Texas Pacific Land Corp shares are higher in after-market hours, with a current price of $358.89 and a market capitalization of $24.75 billion.

14. aug 2026, 23:31 UTC

News

Jana Partners disclosed a new stake in Rapid7 Inc, acquiring over 6.7 million shares. Shares advanced during after-market hours following the announcement.

14. aug 2026, 23:21 UTC

News

MongoDB Inc. showcases AI focus with new Atlas Managed MCP Server tools and Voyage AI features. Shares are little changed in after-market trading.

14. aug 2026, 23:21 UTC

News

Constellation Brands shares are trading lower after Berkshire Hathaway dissolved its stake, contributing to negative sentiment amid broader weakness in the Distillers & Vintners sector.

14. aug 2026, 23:21 UTC

News

Embecta Corp shares are lower in after-market hours amid negative sentiment from two class action lawsuits alleging securities fraud and disappointing second-quarter guidance.

14. aug 2026, 23:11 UTC

News

Lattice Semiconductor granted over 414,000 RSUs and PRSUs to new employees as part of its equity incentive plan. Shares are trading roughly flat in after-market hours.

Võrdlus sarnastega

Hinnamuutus

Mirati Therapeutics Inc Prognoos

Hinnasiht

By TipRanks

-0.05% langus

12 kuu keskmine prognoos

Keskmine 58.67 USD  -0.05%

Kõrge 59 USD

Madal 58 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Mirati Therapeutics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

5 ratings

0

Osta

5

Hoia

0

Müü

Sentiment

By Acuity

86 / 340 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

EBITDA

Ärikasum

$

Ettevõttest Mirati Therapeutics Inc

Mirati Therapeutics, Inc. is a clinical-stage oncology company. It is focused on developing therapeutics to address the genetic and immunological promoters of cancer. Its clinical programs consist of product candidates, including Adagrasib (MRTX849), MRTX1133, and Sitravatinib. MRTX849 is an oral small-molecule therapy designed to shrink difficult-to-treat cancers harboring the KRAS G12C mutation. MRTX1133 is a small molecule-inhibitor of the KRASG12D mutation, designed to treat patients with unmet need. Sitravatinib is a spectrum-selective receptor tyrosine kinase (RTK) inhibitor that can stimulate the body’s immune response to fight cancer. MRTX849 is in Phase III and Phase I/II clinical trials and MRTX1133 is in preclinical development. Sitravatinib is in a Phase III clinical trial, and Phase I/II clinical trials. It also has additional preclinical discovery programs, which includes first-in-class and best-in-class product candidates designed to address mutations and tumors.
help-icon Live chat